# Phase 0, Phase 1 & Phase 2 Progress Summary

## ✅ Phase 0: Fail Now vs Later - COMPLETED

All critical gap validations completed:
- ✅ Disease parameter flow fixed
- ✅ Pathway weight structure extended (DDR, PI3K, VEGF)
- ✅ Panel selection logic updated (disease-aware)
- ✅ Dossier mutations check added
- ✅ Ovarian panel structure validated

## ✅ Phase 1: Backend SOTA - COMPLETED

All backend SOTA tasks completed:
- ✅ **Task 1.0**: Disease-aware panel selection implemented
- ✅ **Task 1.1**: Ovarian cancer pathway configuration (DDR pathway)
- ✅ **Task 1.2**: Ovarian cancer evidence integration (PARP MoA terms, BRCA truncating boost)
- ✅ **Task 1.3**: Melanoma full-mode integration (MAPK pathway, evidence enabled)
- ✅ **Task 1.4**: Standardized benchmark scripts created (MM, ovarian, melanoma)

**Remaining**: Task 1.5 (Calibration Improvements) - Optional enhancement

## ✅ Phase 2: Frontend Integration - IN PROGRESS

### Task 2.1: Integrate S/P/E into Dossier Generation - ✅ COMPLETED
- ✅ Efficacy prediction integrated into `dossier_generator.py`
- ✅ Top 5 drugs with S/P/E breakdown included in dossier
- ✅ Dossier renderer updated to include efficacy section in markdown
- ✅ Section 6: Drug Efficacy Analysis (S/P/E) added to markdown output

### Task 2.2: Frontend Dossier Components - ⏳ PENDING
- Frontend components need to be updated to display efficacy section
- Files to modify:
  - `oncology-frontend/src/components/dossier/DossierView.jsx`
  - `oncology-frontend/src/components/ClinicalGenomicsCommandCenter/cards/EfficacyCard.jsx`

### Task 2.3: Frontend API Integration - ⏳ PENDING
- Frontend hooks and API integration needed
- Files to create/modify:
  - `oncology-frontend/src/hooks/useDossierGeneration.js`
  - `oncology-frontend/src/components/dossier/DossierGenerator.jsx`

## 📊 Benchmark Results

### MM Benchmark
- **Accuracy**: 40% (2/5 correct)
- **Target**: 100% pathway alignment
- **Issue**: KRAS/NRAS variants ranking BRAF inhibitor higher than MEK inhibitor

### Ovarian Benchmark
- **AUROC**: 0.500 (below target of 0.65)
- **Issue**: Limited test data (only 2 variants), needs full TCGA-OV dataset

### Melanoma Benchmark
- **Accuracy**: 50% (2/4 correct)
- **Confidence**: 0.400 (below target of 0.50)
- **Issue**: NRAS variants ranking BRAF inhibitor higher than MEK inhibitor

## 🔧 Backend Status

**Status**: ✅ **RUNNING** on http://127.0.0.1:8000

**Dependencies Installed**:
- ✅ email-validator
- ✅ google-generativeai
- ✅ astrapy

**All API Tests**: ✅ **PASSING** (4/4)

## 📝 Key Files Modified

### Backend Core
1. `api/services/pathway/panel_config.py` - Disease-aware panels
2. `api/services/pathway/drug_mapping.py` - Extended pathway mappings
3. `api/services/evidence/literature_client.py` - PARP/platinum evidence integration
4. `api/services/efficacy_orchestrator/orchestrator.py` - Disease parameter flow
5. `api/services/client_dossier/dossier_generator.py` - Efficacy integration
6. `api/services/client_dossier/dossier_renderer.py` - Efficacy section in markdown
7. `api/routers/clinical_genomics.py` - Full-mode evidence support

### Benchmark Scripts
1. `scripts/benchmark_sota_mm.py` - MM benchmark
2. `scripts/benchmark_sota_ovarian.py` - Ovarian benchmark
3. `scripts/benchmark_sota_melanoma.py` - Melanoma benchmark

## 🎯 Next Steps

1. **Complete Phase 2.2 & 2.3**: Frontend components and API integration
2. **Task 1.5**: Calibration improvements (optional)
3. **Benchmark Enhancement**: Use full TCGA-OV dataset for ovarian benchmark
4. **Pathway Scoring Tuning**: Improve KRAS/NRAS → MEK inhibitor ranking

## ✅ Success Criteria Status

- ✅ Disease-aware panels: Working
- ✅ Pathway mappings: Extended and working
- ✅ Evidence integration: PARP/platinum working
- ✅ Dossier efficacy: Integrated and rendering
- ⚠️ Benchmark accuracy: Needs improvement (calibration)
- ⏳ Frontend integration: Pending

